Roubin Gary S bought 153,846 shares of InspireMD, Inc. at $0.65 for $100k on Nov 13, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$99,999.90Shares × reported price
Shares traded
153,846Common Stock
Price per share
$0.65Reported price. Read footnotes for ranges.
% of reported position traded
18.44%This security and ownership context
Holdings after
988,324Direct
Trade date
Nov 13, 2026Buy
Filed
Nov 17, 2026, 4:05 PM ET4-day reporting delay
Accession
0001493152-26-052820Code P · Transaction 403022
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 834,478 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

NSPR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NSPR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +2.2%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents shares of common stock purchased by the Reporting Person in the Issuer's underwritten public offering at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants. F2: The Series L common stock warrants are immediately exercisable at an exercise price of $0.65 per share and expire on November 16, 2027.